Download PDF
Int J Angiol 2022; 31(03): 143-149
DOI: 10.1055/s-0042-1756204
Invited Article

Pathophysiology and Management of Pulmonary Embolism

Ishan K. Shah
1   Department of Family Medicine, Mayo Clinic Health System, La Crosse, Wisconsin
,
John M. Merfeld
1   Department of Family Medicine, Mayo Clinic Health System, La Crosse, Wisconsin
,
Jimy Chun
2   Department of Nephrology, Mayo Clinic, La Crosse, Wisconsin
,
Tahir Tak
3   Department of Cardiovascular Diseases, Mayo Clinic Health System, La Crosse, Wisconsin
4   Department of Cardiovascular Diseases, Mayo Clinic, Rochester. Minnesota
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Pulmonary embolism (PE) is one of the most common etiologies of cardiovascular mortality. It could be linked to several risk factors including advanced age. The pathogenesis of PE is dictated by the Virchow's triad that includes venous stasis, endothelial injury, and a hypercoagulable state. The diagnosis of PE is difficult and is often missed due to the nonspecific symptomatology. Hypoxia is common in the setting of PE, and the degree of respiratory compromise is multifactorial and influenced by underlying cardiac function, clot location, and ability to compensate with respiratory mechanics. Right ventricular dysfunction/failure is the more profound cardiovascular impact of acute PE and occurs due to sudden increase in afterload. This is also the primary cause of death in PE. High clinical suspicion is required in those with risk factors and presenting signs or symptoms of venous thromboembolic disease, with validated clinical risk scores such as the Wells, Geneva, and pulmonary embolism rule out criteria in estimating the likelihood for PE. Advancement in capture time and wider availability of computed tomographic pulmonary angiography and D-dimer testing have further facilitated the rapid evaluation and diagnosis of suspected PE. Treatment is dependent on clinical presentation and initially involves providing adequate oxygenation and stabilizing hemodynamics. Anticoagulant therapy is indicated for the treatment of PE. Treatment is guided by presence or absence of shock and ranges from therapeutic anticoagulation to pharmacologic versus mechanical thrombectomy. The prognosis of patients can vary considerably depending on the cardiac and pulmonary status of patient and the size of the embolus.

Keywords

pulmonary embolism - pulmonary angiography - pulmonary hypertension - hypoxia - Virchow's triad - thromboembolic disease - deep venous thrombosis


Publication History

Article published online:
23 September 2022

© 2022. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Raskob GE, Angchaisuksiri P, Blanco AN. et al; ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. Semin Thromb Hemost 2014; 40 (07) 724-735
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Anderson Jr FA, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 2007; 82 (09) 777-782
    CrossrefPubMedGoogle Scholar
  • 3 Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton III LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158 (06) 585-593
    CrossrefPubMedGoogle Scholar
  • 4 Dudzinski DM, Giri J, Rosenfield K. Interventional treatment of pulmonary embolism. Circ Cardiovasc Interv 2017; 10 (02) e004345
    CrossrefPubMedGoogle Scholar
  • 5 Huet Y, Lemaire F, Brun-Buisson C. et al. Hypoxemia in acute pulmonary embolism. Chest 1985; 88 (06) 829-836
    CrossrefPubMedGoogle Scholar
  • 6 Tsang JY, Hogg JC. Gas exchange and pulmonary hypertension following acute pulmonary thromboembolism: has the emperor got some new clothes yet?. Pulm Circ 2014; 4 (02) 220-236
    CrossrefPubMedGoogle Scholar
  • 7 Wilson III JE, Pierce AK, Johnson Jr RL. et al. Hypoxemia in pulmonary embolism, a clinical study. J Clin Invest 1971; 50 (03) 481-491
    CrossrefPubMedGoogle Scholar
  • 8 Stein PD, Terrin ML, Hales CA. et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 1991; 100 (03) 598-603
    CrossrefPubMedGoogle Scholar
  • 9 Calkovska A, Mokra D, Calkovsky V. Lung surfactant alterations in pulmonary thromboembolism. Eur J Med Res 2009; 14 (Suppl. 04) 38-41
    CrossrefPubMedGoogle Scholar
  • 10 Gurewich V, Thomas D, Stein M, Wessler S. Bronchoconstriction in the presence of pulmonary embolism. Circulation 1963; 27: 339-345
    CrossrefPubMedGoogle Scholar
  • 11 Lele EE, Hantos Z, Bitay M. et al. Bronchoconstriction during alveolar hypocapnia and systemic hypercapnia in dogs with a cardiopulmonary bypass. Respir Physiol Neurobiol 2011; 175 (01) 140-145
    CrossrefPubMedGoogle Scholar
  • 12 Konstantinides S, Geibel A, Kasper W, Olschewski M, Blümel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 1998; 97 (19) 1946-1951
    CrossrefPubMedGoogle Scholar
  • 13 Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008; 117 (13) 1717-1731
    CrossrefPubMedGoogle Scholar
  • 14 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353 (9162): 1386-1389
    CrossrefPubMedGoogle Scholar
  • 15 Smulders YM. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res 2000; 48 (01) 23-33
    CrossrefPubMedGoogle Scholar
  • 16 Cingolani HE, Pérez NG, Cingolani OH, Ennis IL. The Anrep effect: 100 years later. Am J Physiol Heart Circ Physiol 2013; 304 (02) H175-H182
    CrossrefPubMedGoogle Scholar
  • 17 Nootens M, Kaufmann E, Rector T. et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol 1995; 26 (07) 1581-1585
    CrossrefPubMedGoogle Scholar
  • 18 Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol 2013; 18 (02) 129-138
    PubMedGoogle Scholar
  • 19 Vlahakes GJ, Turley K, Hoffman JI. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 1981; 63 (01) 87-95
    CrossrefPubMedGoogle Scholar
  • 20 van Wolferen SA, Marcus JT, Westerhof N. et al. Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J 2008; 29 (01) 120-127
    CrossrefPubMedGoogle Scholar
  • 21 Iwadate K, Doi M, Tanno K. et al. Right ventricular damage due to pulmonary embolism: examination of the number of infiltrating macrophages. Forensic Sci Int 2003; 134 (2-3): 147-153
    CrossrefPubMedGoogle Scholar
  • 22 Watts JA, Zagorski J, Gellar MA, Stevinson BG, Kline JA. Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. J Mol Cell Cardiol 2006; 41 (02) 296-307
    CrossrefPubMedGoogle Scholar
  • 23 Ullman E, Brady WJ, Perron AD, Chan T, Mattu A. Electrocardiographic manifestations of pulmonary embolism. Am J Emerg Med 2001; 19 (06) 514-519
    CrossrefPubMedGoogle Scholar
  • 24 Perrier A, Desmarais S, Goehring C. et al. D-dimer testing for suspected pulmonary embolism in outpatients. Am J Respir Crit Care Med 1997; 156 (2 Pt 1): 492-496
    CrossrefPubMedGoogle Scholar
  • 25 Schoepf UJ, Costello P. CT angiography for diagnosis of pulmonary embolism: state of the art. Radiology 2004; 230 (02) 329-337
    Google Scholar
  • 26 Sostman HD, Miniati M, Gottschalk A, Matta F, Stein PD, Pistolesi M. Sensitivity and specificity of perfusion scintigraphy combined with chest radiography for acute pulmonary embolism in PIOPED II. J Nucl Med 2008; 49 (11) 1741-1748
    CrossrefPubMedGoogle Scholar
  • 27 Lucassen W, Geersing GJ, Erkens PM. et al. Clinical decision rules for excluding pulmonary embolism: a meta-analysis. Ann Intern Med 2011; 155 (07) 448-460
    CrossrefPubMedGoogle Scholar
  • 28 Husted S, de Caterina R, Andreotti F. et al; ESC Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease. Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel. Thromb Haemost 2014; 111 (05) 781-782
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Konstantinides SV, Meyer G, Becattini C. et al; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41 (04) 543-603
    Google Scholar